The study aimed to identify colonized patients as a possible source of eventual VRE (vancomycin-resistant enterococci) infection from stool samples positive for glutamate dehydrogenase antigen, as well as for Clostridioides difficile toxins A and B. The study was carried out from 7/2020 to 9/2021. Stool samples were grown in a brain heart infusion medium with a gram-positive non-spore-forming bacteria supplement under aerobic conditions. The samples for VRE identification were grown on CHROMID® VRE agar, and the MICs for vancomycin and teicoplanin were also estimated. The presence of the vanA/vanB genes was tested using the PCR method. The total number of 113 stool samples positive for Clostridioides difficile toxins was analyzed. Of these samples, 44 isolates with VRE characters were identified. The most prevalent isolates in our set of isolates were Enterococcus faecium (27 isolates, 62%), Enterococcus faecalis (9 isolates, 21%), Enterococcus solitarius (4 isolates, 9%), Enterococcus durans (2 isolates, 4%), 1 isolate Enterococcus sulfurous (2%), and Enterococcus raffinosus (2%). In total, 26 isolates were detected in the study in the presence of vanA genes (24 isolates E. faecium, 2 isolates E. faecalis) and 18 isolates detected in the presence of vanB genes (7 isolates E. faecalis, 4 isolates E. solitarius, 3 isolates E. faecium, 2 isolates E. durans, 1 isolate E. sulfurous, and E. raffinosus). The results of this study showed the local dominance character of the vanA gene of hospital VRE isolates that were carriers of genes associated with high resistance to vancomycin, teicoplanin, and occasionally linezolid.

Biomedical Research Center Institute of Virology Slovak Academy of Sciences Bratislava Slovakia

Catholic University Ružomberok Slovakia

Czech Anaerobic Bacteria Reference Laboratory Faculty of Medicine Institute of Laboratory Medicine University of Ostrava Ostrava Czech Republic

Faculty of Medicine Institute of Laboratory Medicine University of Ostrava Ostrava Czech Republic

Faculty of Medicine University of Ostrava Ostrava Czech Republic

Laboratory of Clinical Microbiology Faculty Hospital Central Military Hospital Ružomberok Slovakia

Science and Research Department Faculty Hospital Central Military Hospital Ružomberok Slovakia

St Elizabeth University in Bratislava Catholic University Ružomberok Slovakia

Zobrazit více v PubMed

Agegne A, Abera B, Derbie A, Yismae G, Shiferaw MB. Magnitude of vancomycin-resistant Enterococci (VRE) colonization among HIV-infected patients attending ART clinic in West Amhara government hospitals. Int J Microbiol Article ID. 2018;7510157:1–7. doi: 10.1155/2018/7510157. PubMed DOI PMC

Büchler AC, Ragozzino S, Wicki M, Spaniol V, Jäger S, Seth-Smith HMB, Goldenberger D, Hinic V, Egli A, Frei R, Widmer AF. Patients exposed to vancomycin-resistant enterococci during in hospital outbreaks in a low endemic setting: a proposal for risk-based screening. Antimicrob Resist Infect Control Article ID. 2022;11:60. doi: 10.1186/s13756-022-01089-9. PubMed DOI PMC

Cattoir V, Leclerccq R. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother. 2012;68(4):731–742. doi: 10.1093/jac/dks469. PubMed DOI

Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686–707. doi: 10.1128/cmr.13.4.686-707.2000. PubMed DOI PMC

Chanderraj R, Brown ChA, Hinkle K, Falkowski N, Ranjan P, Dickson RP, Woods RJ (2020) Gut microbiota predict Enterococcus expansion but not vancomycin-resistant Enterococcus acquisition. mSphere 5(6). 10.1128/mSphere.00537-20 PubMed PMC

Correa-Martínez CL, Hagemeier NCJ, Frobose NJ, Kampmeier S (2021) Impact of Clostridioides difficult therapy on the nosocomial acquisition of vancomycin-resistant enterococci. Pharmaceuticals 14(11). 10.3390/ph14111066 PubMed PMC

De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Chembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):1–49. doi: 10.1128/CMR.00181-19. PubMed DOI PMC

Egan SA, Kavanagh NL, Shore AC, Mollerup S, Samaniego Castruita JA, Connell O, B, McManus B, Brennan GI, Pinholt M, Westh H, Voleman DC Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland. J Antimicrob Chemother. 2022 doi: 10.1093/jac/dkab393. PubMed DOI PMC

Eliopoulos GM, Gold HS. Vancomycin-resistant enterococci: mechanisms and clinical observations. Clin Infect Dis. 2001;33(2):210–219. doi: 10.1086/321815. PubMed DOI

Faron ML, Lebedoer NA, Buchan BW. Resistance mechanisms, epidemiology and approaches to screening for vancomycin-resistant Enterococcus in the health care setting. J Clin Microbiol. 2016;54(10):1–12. doi: 10.1128/JCM.00211-16. PubMed DOI PMC

Fujiya Y, Harada T, Sugawara Y, Akeda Y, Yasuda M, Masumi A, Hayashi J, Tanimura N, Tsujimoto Y, Shibata W, Yamaguchi T, Kawahara R, Nishi I, Hamada S, Tomono K, Kayeka H (2021) Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a nonendemic area, Japan. Sci Rep 11:14780. 10.1038/s41598-021-94213-5 PubMed PMC

Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421–569. doi: 10.4161/viru.21282. PubMed DOI PMC

Krawczyk B, Wysocka M, Kotlowski R, Bronk M, Michalik M, Samet A (2020) Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland- commensals or hospital-adapted pathogens? PloS One 15:(5).  10.1371/journal.pone.0233504 PubMed PMC

Miller RW, Munita JM, Arias CA (2014) Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther 12(10):1221–1236. 10.1586/14787210.2014.956092 PubMed PMC

O' Driscoll T and Crank CW (2015) Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217–230. 10.2147/IDR.S54125 PubMed PMC

Özsoy S, Ilky A. Detection of vancomycin-resistant enterococci (VRE) submitted for Clostridium difficile toxin testing. Braz J Microbiol. 2017;48(3):489–492. doi: 10.1016/j.bjm.2016.12.012. PubMed DOI PMC

Praharaj I, Sujatha S, Parija SCh. Phenotypic and genotypic characterization of vancomycin-resistant Enterococcus isolates from clinical specimens. Indian J Med Res. 2013;138(4):549–556. PubMed PMC

Ramos S, Silva V, Dapkevicius MDLE, Poeta IG, P, Enterococci, from harmless bacteria to a pathogen. Microorganisms. 2020;8(8):1–12. doi: 10.3390/microorganisms8081118. PubMed DOI PMC

Rangberg A, Larsen AL, Kacelnik O, Saether HS, Bjorland M, Ringstad J, Jonassen ChM. Molecular analysis and epidemiological typing of vancomycin-resistant Enterococcus outbreak strains. Sci Rep Article Number. 2019;11917:1–11. doi: 10.1038/s41598-019-48436-2. PubMed DOI PMC

Reinseth IS, Ovchinnikov KV, Tonnesen HH, Carlsen H, Diep DB. The increasing issue of vancomycin-resistant Enterococci and bacteriocin solution. Probiotics Antimicrob. 2020 doi: 10.1007/s12602-019-09618-6. PubMed DOI PMC

Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS. Increasing trend of vancomycin-resistant Enterococci bacteremia in a tertiary care hospital of South India: a three-year prospective study. Indian J Crit Care Med. 2021;25(8):881–885. doi: 10.5005/jp-journals-10071-23916. PubMed DOI PMC

Stogios PJ, Savchenko A (2020) Molecular mechanism of vancomycin resistance. Protein Sci 29(3):654–669. 10.1002/pro.3819 PubMed PMC

Sutter ST, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF (2010) Not all patients with vancomycin-resistant Enterococci need to be isolated. Clin Infect Dis 51 (6):678–83. 10.1086/655824 PubMed

Vehreschild MJGT, Haverkamp M, Lemmen BLM, S, Fätkenheuer G Vancomycin-resistant enterococci (VRE): a reason to isolate? Infection No. 2019;47:7–11. doi: 10.1007/s15010-018-1202-9. PubMed DOI

Werner G, Klare I, Witte W. Arrangement of the vanA gene cluster in enterococci of different ecological origin. FEMS Microbiol Lett. 1997;155(1):55–61. doi: 10.1111/j.1574-6968.1997.tb12685.x. PubMed DOI

Wingler MJ, Patel NR, Travis King S, Wagner JL, Barber KE, Stover KR. Linezolid for treatment of urinary tract infections caused by vancomycin-resistant Enterococci. Pharmacy. 2021;9(4):175. doi: 10.3390/pharmacy9040175. PubMed DOI PMC

Zaheer R, Cook SR, Barbieri R, Goji N, Cameron A, Petkau A, Polo RO, Tymensen L, Stamm C, Song J, Hannon S, Jones T, Church D, Booker CW, Amoako K, Domselaar GV, Read RR, McAllister TA (2020) Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a-Health continuum. Sci Rep 3937. 10.1038/s41598-020-61002-5 PubMed PMC